Kidney transplant recipient thriving without antirejection drugs due to innovative treatment
Kyle Clark teared up as he made calls to his family from an intensive care unit at a hospital in China, where he’d been placed on dialysis.
News Articles
Read the latest news articles on transplantation medicine, new treatments for organ transplant recipients and ImmunoFree.
Gene-edited pig kidney transplanted into a third person, moving xenotransplants closer to trials
In yet another sign of xenotransplantation creeping toward reality, a medical team at NYU Langone Health announced Tuesday that, for the third time, a kidney from a genetically modified pig had been transplanted into a living patient.
OHSU accused of negligence in use of experimental treatment
A new lawsuit filed Aug. 20 in federal court in Portland sheds light on the enormous financial and human costs of the complex clinical trials that underlie modern pharmaceutical breakthroughs.
First-ever combined heart pump & gene-edited pig kidney transplant gives new hope to patient with terminal illness
Surgeons at NYU Langone Health performed the first combined mechanical heart pump and gene-edited pig kidney transplant surgery.
The bone-marrow-transplant revolution
In the fall of 2021, Gabriel Arias felt like his body was “rotting from the inside.” He was diagnosed with acute myeloid leukemia, a form of blood cancer so aggressive that doctors had him hospitalized the day of his biopsy.
National Kidney Foundation Innovation Fund Invests in ImmunoFree
The National Kidney Foundation (NKF) announced today its latest strategic investment through its NKF Innovation Fund. The fund will support ImmunoFree, a pioneering biomedical company dedicated to reshaping the landscape of organ transplantation by eliminating the need for immunosuppressive medications.
Stem cells ease lung transplant rejection
A transfusion of mesenchymal stem cells stabilized and, in some cases, improved transplanted lung function in patients with chronic organ rejection.
Organ transplant milestone: As US crosses 1 million mark, advances offer hope for millions more
Two lingering organ transplantation problems remain – supply and immunosuppressive medication.
Stanford pediatricians transplant kidneys without need for immune-suppressing drugs
Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.